Management of Bladder Cancer: A Comprehensive Text with Clinical Scenarios

ISBN-13: 9781493946822 / Angielski / Miękka / 2016 / 479 str.

Badrinath R. Konety; Sam S. Chang

Opis

Management of bladder cancer provides a single, comprehensive reference source that incorporates all the latest information regarding bladder cancer. The text covers epidemiology and natural history of bladder cancer as well as latest findings regarding the genetics and molecular biology of the disease. Diagnostic and staging evaluation of both non-muscle invasive and invasive bladder cancer is discussed. The text incorporates chapters summarizing new findings regarding markers for the diagnosis of bladder cancer and new diagnostic techniques to enhance traditional methods such as cystoscopy. Risk stratified treatment of non muscle invasive bladder cancer including various approaches to intravesical therapy are reviewed. Current guideline based approaches to management and new data regarding diagnosis and prognostication of muscle invasive bladder cancer is analyzed and summarized. The application of chemotherapy for muscle invasive and advanced disease is discussed and the evidence based application of multimodality therapy highlighted. Finally, gaps in current knowledge and areas for future research are highlighted. Ongoing important clinical trials which could imminently yield significant new knowledge is discussed.Authored by experts in their respective fields, Management of Bladder Cancer will serve as a easy and complete reference source for clinicians, researchers, individuals in training, allied health professionals and medical students in the fields of Urology, Medical Oncology, Radiation Oncology, Basic and Translational Science and Epidemiology.

Recenzje

From the book reviews:

"The target audience is researchers, clinicians, trainees, allied health professionals, and medical students. Given the emphasis and specificity of the chapters on early stage bladder cancer, this book seems most geared to urologists and urology trainees. ... This is a very easy to use, clearly and expertly written, case- and clinical scenario-based reference that will be helpful to all who treat and study bladder cancer." (Jean Hoffman-Censits, Doody's Book Reviews, March, 2015)

Spis treści

I.                   GENERAL CONCEPTS

 

1.      Epidemiology and natural history

Edward Messing and Emil Scosyrev

 

2.      Screening for Bladder Cancer

Laura-Maria Krabbe, Robert S. Svatek and Yair Lotan

 

3.      Pathology and Staging: Histopathology and Cytopathology

Amber Mackey, Farnaz Hasteh and Donna E. Hansel

 

4.      Pathology and Staging: Genetics and Molecular Biology

Sean McAdams and Michael C. Risk

 

5.      Imaging in Localized and Advanced Bladder Cancer

Timothy Kim, Joshua G. Griffin, Jeffrey M. Holzbeierlein and Wade J. Sexton

 

6.      New Imaging Techniques in Staging of Urothelial Carcinoma of the Bladder

Ramdev Konijeti and Adam S. Kibel

 

7.      Socioeconomic issues and improved quality of care

John L. Gore

 

8.      Quality of life measures

Christopher B. Anderson, David F. Penson and Daniel A. Barocas

 

9.      Prognostication and risk assessment

Luis Alex Kluth, Bernie Bochner and Shahrokh F. Shariat

 

10.  Clinical trials and emerging therapeutic strategies in bladder cancer

Richard M. Bambury, Robert B. Sims and Jonathan E. Rosenberg

 

 

II.                NON MUSCLE INVASIVE BLADDER CANCER

 

11.  Improved diagnostic techniques

Seth P. Lerner and Alvin C. Goh

 

12.  Clinical scenario: Microscopic hematuria and atypical cytology in a 68 year old man with normal upper tract imaging

Christopher S. Gomez, Mark S. Soloway, Jorge Caso, Claudia P. Rojas and Merce Jorda

 

13.  Localized surgical therapy and surveillance

Manish I. Patel and Paul D. Sved

 

14.  Clinical Scenario: Initial high grade Ta tumor

Jose L. Dominguez-Escrig and Eduardo Solsona Narbón

 

15.  Clinical Scenario: Recurrent Ta tumor

Joseph A. Gillespie and Michael A. O'Donnell

 

16.  Clinical Scenario: Rapidly growing, high volume, low grade Ta tumor

James S. Rosoff and Thomas A. Keane

 

17.  Clinical Scenario: Low grade T1 tumor

J. Alfred Witjes and Florine W.M. Schlatmann

 

18.  Intravesical therapy

Jennifer J. Ahn and James M. McKiernan

 

19.  Clinical Scenario: Initial CIS

Sima P. Porten and Colin P. Dinney

 

20.  Management of BCG Recurrent Bladder Cancer

Tracy M. Downs, Daniel J. Lee and Douglass S. Scherr

 

21.  Clinical Scenario: Persistent CIS and HIGH Grade Ta Bladder Cancer after BCG

Maurizio Brausi

 

22.  Clinical Scenario: Presentation and Management of Significant Side Effects from Bacillus Calmette-Guérin Bladder Instillation

Donald L. Lamm and Nilay M. Gandhi

 

23.  Guideline-based management of non-muscle invasive bladder cancer: comparison of the AUA, EAU, ICUD and NCCN guidelines

Jeffrey C. Bassett, John D. Seigne and Peter E. Clark

 

 

III.             MUSCLE INVASIVE BLADDER CANCER

 

24.  Open Radical Cystectomy

J. Joy Lee, Dipen J. Parekh and Mark L. Gonzalgo

 

25.  Robotic cystectomy

Michael Woods, Raj Pruthi and Erik P. Castle

 

26.  Clinical Scenario: T2 bladder tumor

Richard E. Hautmann

 

27.  Urinary Diversion: Open and robotic techniques

Norm D. Smith, Gary D. Steinberg and Cheryl T. Lee

 

28.  Chemoradiotherapy

Christian Weiss and Claus Rödel

 

29.  Clinical Scenario: 53 year-old man with a solitary, 2 cm, high-grade T2 tumor and focal CIS in the bladder dome who wants bladder preservation

Albert J. Chang, Maurice Marcel Garcia and Mack Roach III

 

30.  Management of Bladder Cancer, role of chemotherapy and controversies surrounding its application

Gautam Jha, Guru Sonpavde and Zeeshan Ahmad

 

31.  Clinical Scenario: Large volume, non metastatic T2 bladder tumor

Chad R. Ritch and Michael S. Cookson

 

32.  The role of pelvic lymphadenectomy at the time of radical cystectomy for bladder cancer

Samuel D. Kaffenberger, Todd M. Morgan and Anne K. Schuckman

 

33.  Clinical Scenario: Unexpected positive nodes at radical cystectomy

Christian Thomas and Joachim W. Thüroff

 

34.  Surveillance and monitoring

Daniel J. Canter, Joseph Zabell, Stephen A. Boorjian and Christopher J. Weight

 

35.  Clinical Scenario: The Role of Perioperative Chemotherapy

Eila C. Skinner

 

36.  Management of Bladder Cancer with Pelvic Nodal Metastases After Complete Response to Chemotherapy

Adam C. Reese and Mark P. Schoenberg

 

37.  Guideline based management muscle-invasive bladder cancer: NCCN, ICUD and EAU

Amanda N. Calhoun and Kamal S. Pohar

O autorze

Badrinath R. Konety, MD, MBA, FACS

Professor and Chair, Dept. of Urology

Dougherty Family Chair in Urologic Oncology

Associate Director for Clinical Affairs, Masonic Cancer Center

University of Minnesota

MMC 394, 420 Delaware St

Minneapolis MN 55455, USA

 

Sam S. Chang, MD, FACS

Professor of Urologic Surgery

Patricia and Rodes Hart Chair of Urologic Surgery

Department of Urologic Surgery

Vanderbilt University Medical Center

MCN A 1302, VUMC

Nashville, TN 37232, USA

Blurb

This book provides a single, comprehensive reference source that incorporates the epidemiology, natural history, and the latest genetic and molecular biological findings of bladder cancer. This book discusses the diagnostic and staging evaluation of both non-muscle invasive and invasive bladder cancer and incorporates the new findings on markers for the diagnosis of bladder cancer. Risk stratified treatment of non-muscle invasive bladder cancer including various approaches to intravesical therapy are reviewed. Current guideline-based approaches to management and new data regarding diagnosis and prognostication of muscle invasive bladder cancer is analyzed and summarized. This book covers the application of chemotherapy for muscle invasive and advanced disease. The evidence-based application of multimodality therapy is highlighted. Gaps in current knowledge and important areas for clinical  research are highlighted.

Authored by experts in their respective fields, Management of Bladder Cancer: A Comprehensive Text with Clinical Scenarios serves as an easy and complete reference source for clinicians, researchers, individuals in training, allied health professionals and medical students in the fields of Urology, Medical Oncology, Radiation Oncology, Basic and Translational Science and Epidemiology.